

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mannose metabolic process (GO:0006013) | 9.88358131 |
| 2 | axoneme assembly (GO:0035082) | 8.32538298 |
| 3 | citrulline biosynthetic process (GO:0019240) | 7.90120316 |
| 4 | germinal center formation (GO:0002467) | 7.61662692 |
| 5 | left/right pattern formation (GO:0060972) | 7.47261610 |
| 6 | opsonization (GO:0008228) | 7.45831043 |
| 7 | endothelial cell chemotaxis (GO:0035767) | 7.42951313 |
| 8 | * regulation of apoptotic cell clearance (GO:2000425) | 7.41167492 |
| 9 | production of molecular mediator involved in inflammatory response (GO:0002532) | 7.06019298 |
| 10 | regulation of cilium movement (GO:0003352) | 6.95339357 |
| 11 | primary alcohol catabolic process (GO:0034310) | 6.59669233 |
| 12 | complement activation (GO:0006956) | 6.49701701 |
| 13 | cellular extravasation (GO:0045123) | 6.49401468 |
| 14 | regulation of T cell chemotaxis (GO:0010819) | 6.35635181 |
| 15 | positive regulation of T cell chemotaxis (GO:0010820) | 6.35635181 |
| 16 | regulation of endothelial cell chemotaxis (GO:2001026) | 6.26966073 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.26020979 |
| 18 | negative regulation of cell killing (GO:0031342) | 6.26020979 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 6.08714169 |
| 20 | left/right axis specification (GO:0070986) | 6.02808965 |
| 21 | regulation of complement activation (GO:0030449) | 5.87937580 |
| 22 | positive regulation of Rap GTPase activity (GO:0032854) | 5.78315929 |
| 23 | ethanol metabolic process (GO:0006067) | 5.72326452 |
| 24 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 5.66372305 |
| 25 | diterpenoid biosynthetic process (GO:0016102) | 5.60066600 |
| 26 | negative regulation of granulocyte differentiation (GO:0030853) | 5.53677408 |
| 27 | activated T cell proliferation (GO:0050798) | 5.49333695 |
| 28 | ventricular system development (GO:0021591) | 5.47403366 |
| 29 | vitamin transmembrane transport (GO:0035461) | 5.47087173 |
| 30 | regulation of humoral immune response (GO:0002920) | 5.44961757 |
| 31 | response to xenobiotic stimulus (GO:0009410) | 5.39506997 |
| 32 | regulation of protein activation cascade (GO:2000257) | 5.35687030 |
| 33 | regulation of macrophage chemotaxis (GO:0010758) | 5.33251351 |
| 34 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.23518756 |
| 35 | negative regulation of B cell mediated immunity (GO:0002713) | 5.17619672 |
| 36 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 5.17619672 |
| 37 | tolerance induction (GO:0002507) | 5.16394063 |
| 38 | microtubule bundle formation (GO:0001578) | 5.13212901 |
| 39 | citrulline metabolic process (GO:0000052) | 5.02122300 |
| 40 | regulation of T cell migration (GO:2000404) | 5.02110761 |
| 41 | regulation of Rap GTPase activity (GO:0032317) | 4.95241101 |
| 42 | * lipoxygenase pathway (GO:0019372) | 4.85454240 |
| 43 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.84034488 |
| 44 | chronic inflammatory response (GO:0002544) | 4.78095678 |
| 45 | regulation of germinal center formation (GO:0002634) | 4.77338389 |
| 46 | intraciliary transport (GO:0042073) | 4.72302222 |
| 47 | one-carbon compound transport (GO:0019755) | 4.69663112 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 4.66165670 |
| 49 | cilium organization (GO:0044782) | 4.61884792 |
| 50 | complement activation, classical pathway (GO:0006958) | 4.61550788 |
| 51 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.60625439 |
| 52 | leukocyte tethering or rolling (GO:0050901) | 4.56031608 |
| 53 | glomerular epithelial cell development (GO:0072310) | 4.54357002 |
| 54 | protein activation cascade (GO:0072376) | 4.49717416 |
| 55 | cilium assembly (GO:0042384) | 4.47403597 |
| 56 | cyclooxygenase pathway (GO:0019371) | 4.44718855 |
| 57 | negative regulation of humoral immune response (GO:0002921) | 4.41028778 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.32927585 |
| 59 | ethanol oxidation (GO:0006069) | 4.31669642 |
| 60 | regulation of interleukin-5 production (GO:0032674) | 4.31003547 |
| 61 | cytokine production involved in immune response (GO:0002367) | 4.18514058 |
| 62 | peptidyl-arginine modification (GO:0018195) | 4.12137140 |
| 63 | regulation of interleukin-13 production (GO:0032656) | 4.08798987 |
| 64 | leukotriene biosynthetic process (GO:0019370) | 4.07751609 |
| 65 | detection of external biotic stimulus (GO:0098581) | 4.07085660 |
| 66 | iron ion import (GO:0097286) | 3.99967560 |
| 67 | positive regulation of tolerance induction (GO:0002645) | 3.98941022 |
| 68 | virion attachment to host cell (GO:0019062) | 3.92928632 |
| 69 | adhesion of symbiont to host cell (GO:0044650) | 3.92928632 |
| 70 | regulation of lymphocyte migration (GO:2000401) | 3.89299917 |
| 71 | regulation of microtubule-based movement (GO:0060632) | 3.88518416 |
| 72 | sperm capacitation (GO:0048240) | 3.85290654 |
| 73 | centriole assembly (GO:0098534) | 3.84200992 |
| 74 | positive regulation of T cell migration (GO:2000406) | 3.81626805 |
| 75 | microtubule-based movement (GO:0007018) | 3.79169861 |
| 76 | * regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.78082570 |
| 77 | respiratory burst (GO:0045730) | 3.77361595 |
| 78 | negative regulation of interleukin-6 production (GO:0032715) | 3.76456115 |
| 79 | * apoptotic cell clearance (GO:0043277) | 3.76416139 |
| 80 | prostaglandin biosynthetic process (GO:0001516) | 3.76122043 |
| 81 | prostanoid biosynthetic process (GO:0046457) | 3.76122043 |
| 82 | lung epithelium development (GO:0060428) | 3.73437326 |
| 83 | regulation of tolerance induction (GO:0002643) | 3.73144232 |
| 84 | lymphocyte chemotaxis (GO:0048247) | 3.73079280 |
| 85 | leukocyte cell-cell adhesion (GO:0007159) | 3.72275551 |
| 86 | production of molecular mediator of immune response (GO:0002440) | 3.69352322 |
| 87 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.68942198 |
| 88 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.67942682 |
| 89 | protein carboxylation (GO:0018214) | 3.67942682 |
| 90 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.67256479 |
| 91 | protein localization to cilium (GO:0061512) | 3.64909150 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 3.64136979 |
| 93 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.63870001 |
| 94 | retinoic acid metabolic process (GO:0042573) | 3.63843133 |
| 95 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.63445213 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.63321262 |
| 97 | establishment of apical/basal cell polarity (GO:0035089) | 3.57420125 |
| 98 | positive regulation of phagocytosis (GO:0050766) | 3.55455481 |
| 99 | terpenoid biosynthetic process (GO:0016114) | 3.54651906 |
| 100 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.51852882 |
| 101 | lymph node development (GO:0048535) | 3.49951330 |
| 102 | cellular component assembly involved in morphogenesis (GO:0010927) | 3.49451187 |
| 103 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.47960770 |
| 104 | * icosanoid biosynthetic process (GO:0046456) | 3.46990264 |
| 105 | * fatty acid derivative biosynthetic process (GO:1901570) | 3.46990264 |
| 106 | cell projection assembly (GO:0030031) | 3.44131256 |
| 107 | * leukotriene metabolic process (GO:0006691) | 3.43997987 |
| 108 | polyol transport (GO:0015791) | 3.41544114 |
| 109 | negative regulation of macrophage differentiation (GO:0045650) | 3.37827976 |
| 110 | detection of biotic stimulus (GO:0009595) | 3.35702423 |
| 111 | regulation of mononuclear cell migration (GO:0071675) | 3.34205722 |
| 112 | negative regulation of interleukin-2 production (GO:0032703) | 3.33546500 |
| 113 | cilium morphogenesis (GO:0060271) | 3.31224062 |
| 114 | cGMP-mediated signaling (GO:0019934) | 3.30968994 |
| 115 | adaptation of signaling pathway (GO:0023058) | 3.30698782 |
| 116 | adhesion of symbiont to host (GO:0044406) | 3.27959482 |
| 117 | positive regulation of blood coagulation (GO:0030194) | 3.26517684 |
| 118 | positive regulation of hemostasis (GO:1900048) | 3.26517684 |
| 119 | lateral ventricle development (GO:0021670) | 3.25613054 |
| 120 | regulation of antigen processing and presentation (GO:0002577) | 3.23498695 |
| 121 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.22399243 |
| 122 | cytoplasmic microtubule organization (GO:0031122) | 3.21608922 |
| 123 | * regulation of phagocytosis (GO:0050764) | 3.19810634 |
| 124 | cellular response to interleukin-6 (GO:0071354) | 3.15654629 |
| 125 | negative regulation of bone mineralization (GO:0030502) | 3.15310217 |
| 126 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.14323636 |
| 127 | positive regulation of coagulation (GO:0050820) | 3.12193321 |
| 128 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.11395268 |
| 129 | positive regulation of lymphocyte migration (GO:2000403) | 3.11267914 |
| 130 | negative regulation of inclusion body assembly (GO:0090084) | 3.09265530 |
| 131 | O-glycan processing (GO:0016266) | 3.03842652 |
| 132 | oxygen transport (GO:0015671) | 3.03715807 |
| 133 | cardiac epithelial to mesenchymal transition (GO:0060317) | 3.01778539 |
| 134 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98707541 |
| 135 | establishment of monopolar cell polarity (GO:0061162) | 2.98551681 |
| 136 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.98551681 |
| 137 | response to methylmercury (GO:0051597) | 2.95633016 |
| 138 | hypotonic response (GO:0006971) | 2.94828300 |
| 139 | prostanoid metabolic process (GO:0006692) | 2.94046632 |
| 140 | prostaglandin metabolic process (GO:0006693) | 2.94046632 |
| 141 | primary alcohol metabolic process (GO:0034308) | 2.89855309 |
| 142 | T cell mediated immunity (GO:0002456) | 2.89388841 |
| 143 | retinol metabolic process (GO:0042572) | 2.89218982 |
| 144 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.88562516 |
| 145 | import into cell (GO:0098657) | 2.86439098 |
| 146 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.83378022 |
| 147 | defense response to Gram-negative bacterium (GO:0050829) | 2.81935739 |
| 148 | regulation of cell adhesion mediated by integrin (GO:0033628) | 2.81780012 |
| 149 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.80969675 |
| 150 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.80969675 |
| 151 | * unsaturated fatty acid biosynthetic process (GO:0006636) | 2.80823401 |
| 152 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.79051629 |
| 153 | regulation of interleukin-4 production (GO:0032673) | 2.77409335 |
| 154 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.76988896 |
| 155 | modulation by symbiont of host immune response (GO:0052553) | 2.76988896 |
| 156 | positive regulation by symbiont of host defense response (GO:0052509) | 2.76988896 |
| 157 | modulation by symbiont of host defense response (GO:0052031) | 2.76988896 |
| 158 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76988896 |
| 159 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.73279039 |
| 160 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.71634759 |
| 161 | multicellular organismal water homeostasis (GO:0050891) | 2.71223584 |
| 162 | histone H3-K36 demethylation (GO:0070544) | 2.69892456 |
| 163 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.68033999 |
| 164 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.65802288 |
| 165 | regulation of autophagic vacuole assembly (GO:2000785) | 2.62277628 |
| 166 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.62197107 |
| 167 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.61271991 |
| 168 | exogenous drug catabolic process (GO:0042738) | 2.55488208 |
| 169 | amyloid precursor protein catabolic process (GO:0042987) | 2.51808217 |
| 170 | establishment of planar polarity (GO:0001736) | 2.50012191 |
| 171 | establishment of tissue polarity (GO:0007164) | 2.50012191 |
| 172 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.48567828 |
| 173 | reactive oxygen species biosynthetic process (GO:1903409) | 2.39001776 |
| 174 | filopodium assembly (GO:0046847) | 2.37630058 |
| 175 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.37010735 |
| 176 | microtubule depolymerization (GO:0007019) | 2.35963351 |
| 177 | glutathione derivative metabolic process (GO:1901685) | 2.35234111 |
| 178 | glutathione derivative biosynthetic process (GO:1901687) | 2.35234111 |
| 179 | negative regulation of type 2 immune response (GO:0002829) | 2.33927644 |
| 180 | microtubule polymerization or depolymerization (GO:0031109) | 2.33418792 |
| 181 | water homeostasis (GO:0030104) | 2.32498185 |
| 182 | regulation of vacuole organization (GO:0044088) | 2.32486421 |
| 183 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.32148656 |
| 184 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.32122662 |
| 185 | regulation of microtubule depolymerization (GO:0031114) | 2.29208129 |
| 186 | * negative regulation of adaptive immune response (GO:0002820) | 2.28895849 |
| 187 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.27862852 |
| 188 | regulation of response to osmotic stress (GO:0047484) | 2.25172469 |
| 189 | progesterone metabolic process (GO:0042448) | 2.23744550 |
| 190 | axonemal dynein complex assembly (GO:0070286) | 18.6940665 |
| 191 | cilium or flagellum-dependent cell motility (GO:0001539) | 16.1502069 |
| 192 | cilium movement (GO:0003341) | 13.5203057 |
| 193 | motile cilium assembly (GO:0044458) | 12.4954033 |
| 194 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 12.3373172 |
| 195 | regulation of integrin activation (GO:0033623) | 12.2927579 |
| 196 | epithelial cilium movement (GO:0003351) | 11.1866857 |
| 197 | complement activation, alternative pathway (GO:0006957) | 10.6074335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.73788359 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.62623794 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 4.29062412 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.41600115 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.29809623 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.27973489 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.94330131 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.89450374 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.80993174 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78311587 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.74634821 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.60841676 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55056601 |
| 14 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.53963914 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.43371639 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38966548 |
| 17 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.29416898 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.17255295 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.16452374 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.13495714 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12685289 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.10139857 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07355939 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.02413249 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02137027 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.96724359 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.95782865 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95752997 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91419076 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89858751 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87784197 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87431847 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87274832 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86010176 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83469173 |
| 36 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.80418668 |
| 37 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.71970746 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.71925295 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.71147458 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70319360 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.69293786 |
| 42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.68659889 |
| 43 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.67201261 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.66727102 |
| 45 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.65788219 |
| 46 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.65145777 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63083159 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61831790 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.60682270 |
| 50 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59943835 |
| 51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.59610240 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58608757 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.58420042 |
| 54 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.56269573 |
| 55 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.52266491 |
| 56 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51732081 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51509799 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48270601 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.47675207 |
| 60 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46537421 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45805702 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43913417 |
| 63 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.42502873 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41271151 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40965216 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40912893 |
| 67 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40639623 |
| 68 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.40267206 |
| 69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.38191760 |
| 70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37804607 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37767474 |
| 72 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.35210181 |
| 73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.35204427 |
| 74 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.35098086 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34479523 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34163201 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31267539 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 1.30988278 |
| 79 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.29579404 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29102334 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.28648050 |
| 82 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27584182 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26031907 |
| 84 | MAF_26560356_Chip-Seq_TH1_Human | 1.25082971 |
| 85 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24220026 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23859554 |
| 87 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.23620231 |
| 88 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.22648601 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22577794 |
| 90 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.21379446 |
| 91 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.20421115 |
| 92 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19477034 |
| 93 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19208403 |
| 94 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18516453 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17922914 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16109548 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15533165 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15128737 |
| 99 | MYB_26560356_Chip-Seq_TH2_Human | 1.13952048 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13951384 |
| 101 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13555726 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.13261122 |
| 103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12818886 |
| 104 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12567421 |
| 105 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12468576 |
| 106 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11068133 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11061297 |
| 108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10406470 |
| 109 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10397448 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10346933 |
| 111 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10332604 |
| 112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08982969 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08508718 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08448803 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08293345 |
| 116 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07515847 |
| 117 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07435172 |
| 118 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06840066 |
| 119 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05400264 |
| 120 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04399617 |
| 121 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04225065 |
| 122 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04114921 |
| 123 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03978891 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02716745 |
| 125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01266968 |
| 126 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01172930 |
| 127 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01108710 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00868580 |
| 129 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00096397 |
| 130 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99823229 |
| 131 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99349776 |
| 132 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98924769 |
| 133 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98437737 |
| 134 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.97367572 |
| 135 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96908216 |
| 136 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96088330 |
| 137 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95972947 |
| 138 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95655889 |
| 139 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95539278 |
| 140 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95390546 |
| 141 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93804567 |
| 142 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93453781 |
| 143 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.93317180 |
| 144 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93190425 |
| 145 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92726939 |
| 146 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92726939 |
| 147 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91759153 |
| 148 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91338655 |
| 149 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90797069 |
| 150 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.90369486 |
| 151 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90239857 |
| 152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87726255 |
| 153 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.83773154 |
| 154 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83606694 |
| 155 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.82610056 |
| 156 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82562160 |
| 157 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82078378 |
| 158 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81692708 |
| 159 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.81465816 |
| 160 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.79929858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008875_abnormal_xenobiotic_pharmacok | 6.02475493 |
| 2 | MP0002132_abnormal_respiratory_system | 4.64217885 |
| 3 | MP0002653_abnormal_ependyma_morphology | 4.62764541 |
| 4 | MP0005058_abnormal_lysosome_morphology | 4.49856227 |
| 5 | MP0003436_decreased_susceptibility_to | 4.09405111 |
| 6 | MP0003724_increased_susceptibility_to | 3.65038120 |
| 7 | MP0005671_abnormal_response_to | 3.55386455 |
| 8 | MP0009840_abnormal_foam_cell | 3.35340176 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 3.25460248 |
| 10 | MP0000685_abnormal_immune_system | 3.19927996 |
| 11 | MP0003075_altered_response_to | 3.16542181 |
| 12 | MP0002277_abnormal_respiratory_mucosa | 3.14041863 |
| 13 | MP0001533_abnormal_skeleton_physiology | 2.89017392 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.85356894 |
| 15 | MP0005025_abnormal_response_to | 2.83818806 |
| 16 | MP0002419_abnormal_innate_immunity | 2.80876258 |
| 17 | MP0003303_peritoneal_inflammation | 2.67822279 |
| 18 | MP0004133_heterotaxia | 2.66624173 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 2.64223792 |
| 20 | * MP0005387_immune_system_phenotype | 2.53495261 |
| 21 | * MP0001790_abnormal_immune_system | 2.53495261 |
| 22 | MP0004043_abnormal_pH_regulation | 2.48950529 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.47236124 |
| 24 | MP0001851_eye_inflammation | 2.45310734 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.44619172 |
| 26 | MP0001984_abnormal_olfaction | 2.36442374 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 2.33744738 |
| 28 | MP0008789_abnormal_olfactory_epithelium | 2.32068942 |
| 29 | MP0001849_ear_inflammation | 2.29722999 |
| 30 | MP0008004_abnormal_stomach_pH | 2.25161597 |
| 31 | MP0005464_abnormal_platelet_physiology | 2.22499245 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 2.21611186 |
| 33 | MP0004510_myositis | 2.15129677 |
| 34 | MP0005377_hearing/vestibular/ear_phenot | 2.14032116 |
| 35 | MP0003878_abnormal_ear_physiology | 2.14032116 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 2.06531505 |
| 37 | MP0001800_abnormal_humoral_immune | 2.02624817 |
| 38 | MP0001958_emphysema | 2.01805050 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.96018000 |
| 40 | MP0005623_abnormal_meninges_morphology | 1.91818108 |
| 41 | MP0004885_abnormal_endolymph | 1.91393227 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.84426810 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.83525419 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.69679196 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.68439553 |
| 46 | MP0000604_amyloidosis | 1.66904674 |
| 47 | MP0001819_abnormal_immune_cell | 1.66519038 |
| 48 | MP0005499_abnormal_olfactory_system | 1.65996370 |
| 49 | MP0005394_taste/olfaction_phenotype | 1.65996370 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.61799644 |
| 51 | MP0002405_respiratory_system_inflammati | 1.60515591 |
| 52 | MP0003279_aneurysm | 1.59919983 |
| 53 | MP0001835_abnormal_antigen_presentation | 1.57737841 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.57489603 |
| 55 | MP0005248_abnormal_Harderian_gland | 1.54762920 |
| 56 | MP0005390_skeleton_phenotype | 1.54354049 |
| 57 | MP0002933_joint_inflammation | 1.52798229 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.51205546 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.50389630 |
| 60 | MP0010678_abnormal_skin_adnexa | 1.47797552 |
| 61 | MP0005023_abnormal_wound_healing | 1.47703421 |
| 62 | MP0001765_abnormal_ion_homeostasis | 1.47486797 |
| 63 | MP0002723_abnormal_immune_serum | 1.43943497 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 1.43895428 |
| 65 | MP0000767_abnormal_smooth_muscle | 1.40419329 |
| 66 | MP0001915_intracranial_hemorrhage | 1.37325556 |
| 67 | * MP0004947_skin_inflammation | 1.35922294 |
| 68 | MP0005647_abnormal_sex_gland | 1.35879203 |
| 69 | MP0003690_abnormal_glial_cell | 1.32305686 |
| 70 | MP0009785_altered_susceptibility_to | 1.32028593 |
| 71 | MP0005166_decreased_susceptibility_to | 1.31751690 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.29610148 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.26814322 |
| 74 | * MP0000716_abnormal_immune_system | 1.26475532 |
| 75 | MP0000383_abnormal_hair_follicle | 1.25329191 |
| 76 | MP0009763_increased_sensitivity_to | 1.24237574 |
| 77 | MP0002396_abnormal_hematopoietic_system | 1.23212635 |
| 78 | MP0001727_abnormal_embryo_implantation | 1.20542129 |
| 79 | MP0002736_abnormal_nociception_after | 1.20509242 |
| 80 | MP0005408_hypopigmentation | 1.18696874 |
| 81 | MP0003638_abnormal_response/metabolism_ | 1.17802307 |
| 82 | MP0005388_respiratory_system_phenotype | 1.16651222 |
| 83 | MP0002133_abnormal_respiratory_system | 1.16651222 |
| 84 | * MP0000689_abnormal_spleen_morphology | 1.14417112 |
| 85 | MP0006082_CNS_inflammation | 1.13048632 |
| 86 | MP0004272_abnormal_basement_membrane | 1.12374494 |
| 87 | MP0003183_abnormal_peptide_metabolism | 1.12057196 |
| 88 | MP0003828_pulmonary_edema | 1.10956684 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 1.10075999 |
| 90 | MP0009278_abnormal_bone_marrow | 1.08881386 |
| 91 | MP0001853_heart_inflammation | 1.04615815 |
| 92 | MP0002254_reproductive_system_inflammat | 1.02109923 |
| 93 | MP0003191_abnormal_cellular_cholesterol | 1.01774341 |
| 94 | MP0002168_other_aberrant_phenotype | 1.01333294 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.99066896 |
| 96 | MP0002006_tumorigenesis | 0.98700176 |
| 97 | MP0005395_other_phenotype | 0.98597802 |
| 98 | MP0003866_abnormal_defecation | 0.98562023 |
| 99 | * MP0002429_abnormal_blood_cell | 0.98386675 |
| 100 | MP0008469_abnormal_protein_level | 0.97761698 |
| 101 | MP0003448_altered_tumor_morphology | 0.97129747 |
| 102 | MP0005164_abnormal_response_to | 0.97013754 |
| 103 | MP0005310_abnormal_salivary_gland | 0.96747150 |
| 104 | MP0000858_altered_metastatic_potential | 0.96482273 |
| 105 | MP0009053_abnormal_anal_canal | 0.95901004 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.95814067 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.94452479 |
| 108 | MP0003252_abnormal_bile_duct | 0.93789897 |
| 109 | MP0005076_abnormal_cell_differentiation | 0.92447648 |
| 110 | * MP0002398_abnormal_bone_marrow | 0.91589520 |
| 111 | MP0005409_darkened_coat_color | 0.91474841 |
| 112 | MP0000343_altered_response_to | 0.91319075 |
| 113 | * MP0002722_abnormal_immune_system | 0.91042703 |
| 114 | MP0002282_abnormal_trachea_morphology | 0.90726632 |
| 115 | * MP0000249_abnormal_blood_vessel | 0.89211415 |
| 116 | MP0005083_abnormal_biliary_tract | 0.88717529 |
| 117 | MP0000566_synostosis | 0.87985134 |
| 118 | MP0003329_amyloid_beta_deposits | 0.87080806 |
| 119 | MP0000490_abnormal_crypts_of | 0.82533796 |
| 120 | MP0003091_abnormal_cell_migration | 0.80606191 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.80487216 |
| 122 | MP0010352_gastrointestinal_tract_polyps | 0.80320638 |
| 123 | MP0010155_abnormal_intestine_physiology | 0.78110405 |
| 124 | MP0004883_abnormal_blood_vessel | 0.77781428 |
| 125 | MP0002135_abnormal_kidney_morphology | 0.76077222 |
| 126 | MP0005670_abnormal_white_adipose | 0.75961775 |
| 127 | MP0001873_stomach_inflammation | 0.73994401 |
| 128 | MP0005220_abnormal_exocrine_pancreas | 0.73573319 |
| 129 | MP0002971_abnormal_brown_adipose | 0.73204197 |
| 130 | MP0005636_abnormal_mineral_homeostasis | 0.71048349 |
| 131 | MP0001545_abnormal_hematopoietic_system | 0.70512247 |
| 132 | MP0005397_hematopoietic_system_phenotyp | 0.70512247 |
| 133 | MP0005165_increased_susceptibility_to | 0.69843898 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.69490344 |
| 135 | MP0002249_abnormal_larynx_morphology | 0.68838475 |
| 136 | * MP0001614_abnormal_blood_vessel | 0.67895202 |
| 137 | MP0000371_diluted_coat_color | 0.67839722 |
| 138 | MP0005332_abnormal_amino_acid | 0.66834320 |
| 139 | MP0001485_abnormal_pinna_reflex | 0.66361763 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.65963352 |
| 141 | MP0001663_abnormal_digestive_system | 0.63160821 |
| 142 | MP0003045_fibrosis | 0.62871509 |
| 143 | MP0009931_abnormal_skin_appearance | 0.62298460 |
| 144 | MP0010329_abnormal_lipoprotein_level | 0.62289195 |
| 145 | MP0010368_abnormal_lymphatic_system | 0.62200143 |
| 146 | MP0000598_abnormal_liver_morphology | 0.60439970 |
| 147 | MP0003634_abnormal_glial_cell | 0.56731634 |
| 148 | MP0009643_abnormal_urine_homeostasis | 0.53145856 |
| 149 | MP0002877_abnormal_melanocyte_morpholog | 0.53128786 |
| 150 | MP0002128_abnormal_blood_circulation | 0.51994686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rhinitis (HP:0012384) | 9.82147912 |
| 2 | Glomerulonephritis (HP:0000099) | 8.23283460 |
| 3 | Chronic bronchitis (HP:0004469) | 7.42014818 |
| 4 | Abnormality of complement system (HP:0005339) | 7.30014763 |
| 5 | Bronchiectasis (HP:0002110) | 7.21862575 |
| 6 | Complement deficiency (HP:0004431) | 6.77300116 |
| 7 | Dysostosis multiplex (HP:0000943) | 5.59980146 |
| 8 | Shallow orbits (HP:0000586) | 5.56887793 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 5.46453440 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.06897298 |
| 11 | Nephritis (HP:0000123) | 4.64291705 |
| 12 | Spondylolisthesis (HP:0003302) | 4.61230491 |
| 13 | Recurrent sinusitis (HP:0011108) | 4.52804041 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.44408528 |
| 15 | Mucopolysacchariduria (HP:0008155) | 4.44408528 |
| 16 | Cervical subluxation (HP:0003308) | 4.31055224 |
| 17 | Bronchitis (HP:0012387) | 4.26376153 |
| 18 | Infertility (HP:0000789) | 4.22891800 |
| 19 | Male infertility (HP:0003251) | 4.18880892 |
| 20 | Recurrent abscess formation (HP:0002722) | 4.16537810 |
| 21 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.12296735 |
| 22 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.12296735 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.12296735 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 4.09838675 |
| 25 | Pustule (HP:0200039) | 3.97963062 |
| 26 | Recurrent otitis media (HP:0000403) | 3.97314541 |
| 27 | Chronic sinusitis (HP:0011109) | 3.96344020 |
| 28 | Wrist flexion contracture (HP:0001239) | 3.94001855 |
| 29 | Loss of speech (HP:0002371) | 3.93453502 |
| 30 | Nasal polyposis (HP:0100582) | 3.90377700 |
| 31 | J-shaped sella turcica (HP:0002680) | 3.88881335 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.67462219 |
| 33 | Bronchomalacia (HP:0002780) | 3.65673128 |
| 34 | Joint stiffness (HP:0001387) | 3.55485153 |
| 35 | Arthropathy (HP:0003040) | 3.43307720 |
| 36 | Peritonitis (HP:0002586) | 3.41279415 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 3.37601968 |
| 38 | Deep venous thrombosis (HP:0002625) | 3.30148121 |
| 39 | Chronic otitis media (HP:0000389) | 3.23033287 |
| 40 | Enlarged penis (HP:0000040) | 3.16813733 |
| 41 | Polygenic inheritance (HP:0010982) | 3.09333513 |
| 42 | Menorrhagia (HP:0000132) | 3.09115569 |
| 43 | Abnormality of the lumbar spine (HP:0100712) | 3.06720207 |
| 44 | Cerebral aneurysm (HP:0004944) | 3.06303552 |
| 45 | Hand muscle atrophy (HP:0009130) | 3.02961004 |
| 46 | Short nail (HP:0001799) | 3.00764756 |
| 47 | Occipital encephalocele (HP:0002085) | 2.98298056 |
| 48 | Deformed sella turcica (HP:0002681) | 2.98112485 |
| 49 | Atelectasis (HP:0100750) | 2.94574566 |
| 50 | Pancreatic fibrosis (HP:0100732) | 2.86531214 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.86193263 |
| 52 | Broad metatarsal (HP:0001783) | 2.85009308 |
| 53 | Hyperactive renin-angiotensin system (HP:0000841) | 2.81277447 |
| 54 | Thoracic kyphosis (HP:0002942) | 2.78443382 |
| 55 | True hermaphroditism (HP:0010459) | 2.68102217 |
| 56 | Abnormality of macrophages (HP:0004311) | 2.65779808 |
| 57 | Multifactorial inheritance (HP:0001426) | 2.65380721 |
| 58 | Turricephaly (HP:0000262) | 2.63266791 |
| 59 | Prolonged partial thromboplastin time (HP:0003645) | 2.63007917 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.55239871 |
| 61 | Abnormality of the common coagulation pathway (HP:0010990) | 2.53797709 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.49114762 |
| 63 | Periodontitis (HP:0000704) | 2.48806982 |
| 64 | Beaking of vertebral bodies (HP:0004568) | 2.48168838 |
| 65 | Gingivitis (HP:0000230) | 2.43896930 |
| 66 | Broad face (HP:0000283) | 2.41994904 |
| 67 | Distal upper limb amyotrophy (HP:0007149) | 2.39597457 |
| 68 | Upper limb amyotrophy (HP:0009129) | 2.39597457 |
| 69 | Flat acetabular roof (HP:0003180) | 2.37699676 |
| 70 | Congenital hepatic fibrosis (HP:0002612) | 2.37680298 |
| 71 | Absent frontal sinuses (HP:0002688) | 2.37204380 |
| 72 | Arterial tortuosity (HP:0005116) | 2.28651285 |
| 73 | Cystic liver disease (HP:0006706) | 2.28607754 |
| 74 | Ovoid vertebral bodies (HP:0003300) | 2.26772195 |
| 75 | Increased cerebral lipofuscin (HP:0011813) | 2.24777399 |
| 76 | Hypoplasia of the odontoid process (HP:0003311) | 2.18098116 |
| 77 | Coarse hair (HP:0002208) | 2.15284181 |
| 78 | Pancreatic cysts (HP:0001737) | 2.13512204 |
| 79 | Molar tooth sign on MRI (HP:0002419) | 2.11128474 |
| 80 | Abnormality of midbrain morphology (HP:0002418) | 2.11128474 |
| 81 | Toxemia of pregnancy (HP:0100603) | 2.09819327 |
| 82 | Recurrent bronchitis (HP:0002837) | 2.09374570 |
| 83 | Nephronophthisis (HP:0000090) | 2.07488664 |
| 84 | Abnormality of the sella turcica (HP:0002679) | 2.05755231 |
| 85 | Abnormality of the thoracic spine (HP:0100711) | 2.04018043 |
| 86 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.03495001 |
| 87 | Vertebral hypoplasia (HP:0008417) | 2.03495001 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 12.9502518 |
| 89 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 12.0440548 |
| 90 | Abnormal respiratory epithelium morphology (HP:0012253) | 10.8723547 |
| 91 | Abnormal respiratory motile cilium morphology (HP:0005938) | 10.8723547 |
| 92 | Abnormal respiratory motile cilium physiology (HP:0012261) | 10.6651294 |
| 93 | Absent/shortened dynein arms (HP:0200106) | 10.5986010 |
| 94 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 10.5986010 |
| 95 | Abnormal ciliary motility (HP:0012262) | 10.5401506 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96795223 |
| 97 | Chronic hepatic failure (HP:0100626) | 1.95991970 |
| 98 | Vascular tortuosity (HP:0004948) | 1.95559379 |
| 99 | Abnormality of the odontoid process (HP:0003310) | 1.94425644 |
| 100 | Postaxial foot polydactyly (HP:0001830) | 1.92144986 |
| 101 | Cellulitis (HP:0100658) | 1.89484508 |
| 102 | Spinal cord compression (HP:0002176) | 1.88395809 |
| 103 | 11 pairs of ribs (HP:0000878) | 1.87377907 |
| 104 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.87090388 |
| 105 | Disproportionate short-trunk short stature (HP:0003521) | 1.87017281 |
| 106 | Severe short stature (HP:0003510) | 1.86650160 |
| 107 | Esophageal varix (HP:0002040) | 1.86274115 |
| 108 | Synostosis involving the elbow (HP:0003938) | 1.85674695 |
| 109 | Humeroradial synostosis (HP:0003041) | 1.85674695 |
| 110 | Mediastinal lymphadenopathy (HP:0100721) | 1.85588878 |
| 111 | Neurofibrillary tangles (HP:0002185) | 1.84902632 |
| 112 | Bell-shaped thorax (HP:0001591) | 1.84876769 |
| 113 | Joint hemorrhage (HP:0005261) | 1.78713668 |
| 114 | Aqueductal stenosis (HP:0002410) | 1.73968812 |
| 115 | Prostate neoplasm (HP:0100787) | 1.73352735 |
| 116 | Thickened calvaria (HP:0002684) | 1.73110166 |
| 117 | Epistaxis (HP:0000421) | 1.69868374 |
| 118 | Radial bowing (HP:0002986) | 1.69824073 |
| 119 | Renal tubular acidosis (HP:0001947) | 1.69650874 |
| 120 | Abnormality of skull ossification (HP:0002703) | 1.68264401 |
| 121 | Pathologic fracture (HP:0002756) | 1.68022467 |
| 122 | Tubulointerstitial nephritis (HP:0001970) | 1.67094941 |
| 123 | Recurrent fungal infections (HP:0002841) | 1.65853682 |
| 124 | Coxa vara (HP:0002812) | 1.65490681 |
| 125 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.65455054 |
| 126 | Recurrent skin infections (HP:0001581) | 1.65329823 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.64222045 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.64222045 |
| 129 | Abnormality of glycolipid metabolism (HP:0010969) | 1.64222045 |
| 130 | Steatorrhea (HP:0002570) | 1.63721330 |
| 131 | Papilloma (HP:0012740) | 1.62525798 |
| 132 | Verrucae (HP:0200043) | 1.62525798 |
| 133 | Anencephaly (HP:0002323) | 1.61648932 |
| 134 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.60795658 |
| 135 | Abnormality of the renal medulla (HP:0100957) | 1.59688221 |
| 136 | Cerebral inclusion bodies (HP:0100314) | 1.59548999 |
| 137 | Progressive neurologic deterioration (HP:0002344) | 1.59420234 |
| 138 | Distal lower limb muscle weakness (HP:0009053) | 1.57347376 |
| 139 | Restrictive lung disease (HP:0002091) | 1.57111664 |
| 140 | Decreased circulating renin level (HP:0003351) | 1.54458398 |
| 141 | Disinhibition (HP:0000734) | 1.53982259 |
| 142 | Nephropathy (HP:0000112) | 1.53037993 |
| 143 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.51941991 |
| 144 | Renal salt wasting (HP:0000127) | 1.51380199 |
| 145 | Oculomotor apraxia (HP:0000657) | 1.50539446 |
| 146 | Abnormality of the frontal sinuses (HP:0002687) | 1.47716992 |
| 147 | Male pseudohermaphroditism (HP:0000037) | 1.47537673 |
| 148 | Hyperkalemia (HP:0002153) | 1.47199256 |
| 149 | Asplenia (HP:0001746) | 1.46583676 |
| 150 | Protuberant abdomen (HP:0001538) | 1.46414936 |
| 151 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.42541167 |
| 152 | Tubular atrophy (HP:0000092) | 1.40578227 |
| 153 | Furrowed tongue (HP:0000221) | 1.38512753 |
| 154 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.36139113 |
| 155 | Ventricular fibrillation (HP:0001663) | 1.35302265 |
| 156 | Glucose intolerance (HP:0000833) | 1.34449850 |
| 157 | Cone-rod dystrophy (HP:0000548) | 1.33664127 |
| 158 | Medial flaring of the eyebrow (HP:0010747) | 1.30965219 |
| 159 | Fat malabsorption (HP:0002630) | 1.29188120 |
| 160 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.24649998 |
| 161 | Hyperaldosteronism (HP:0000859) | 1.24062506 |
| 162 | Congenital primary aphakia (HP:0007707) | 1.24059223 |
| 163 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.20755139 |
| 164 | Abnormality of chloride homeostasis (HP:0011422) | 1.20308181 |
| 165 | Obstructive sleep apnea (HP:0002870) | 1.19269178 |
| 166 | Gait imbalance (HP:0002141) | 1.18271182 |
| 167 | Alveolar cell carcinoma (HP:0006519) | 1.17910770 |
| 168 | Lip pit (HP:0100267) | 1.14397392 |
| 169 | Postaxial hand polydactyly (HP:0001162) | 1.13143997 |
| 170 | Abnormality of the dental root (HP:0006486) | 1.12053148 |
| 171 | Taurodontia (HP:0000679) | 1.12053148 |
| 172 | Abnormality of permanent molar morphology (HP:0011071) | 1.12053148 |
| 173 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.11533901 |
| 174 | Abnormality of renin-angiotensin system (HP:0000847) | 1.10394028 |
| 175 | Sclerocornea (HP:0000647) | 1.09817444 |
| 176 | Spinal muscular atrophy (HP:0007269) | 1.09808986 |
| 177 | Short thorax (HP:0010306) | 1.09345563 |
| 178 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.06076956 |
| 179 | Tubulointerstitial abnormality (HP:0001969) | 1.05940848 |
| 180 | Nephrogenic diabetes insipidus (HP:0009806) | 1.05881440 |
| 181 | Multiple lipomas (HP:0001012) | 1.05734847 |
| 182 | Recurrent pneumonia (HP:0006532) | 1.05592739 |
| 183 | Hyponatremia (HP:0002902) | 1.05246114 |
| 184 | Abnormality of the dental pulp (HP:0006479) | 1.02036723 |
| 185 | Muscle fiber splitting (HP:0003555) | 1.01743354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 9.65815649 |
| 2 | MST1R | 8.49317521 |
| 3 | MST4 | 4.36412715 |
| 4 | BLK | 4.22104747 |
| 5 | MET | 3.41469400 |
| 6 | CAMK1D | 3.32599581 |
| 7 | ERN1 | 3.22069671 |
| 8 | DAPK2 | 3.13533825 |
| 9 | TRIB3 | 2.86085761 |
| 10 | RIPK1 | 2.82240463 |
| 11 | MAP4K1 | 2.68905683 |
| 12 | CAMK1G | 2.61933386 |
| 13 | BMX | 2.53191383 |
| 14 | PKN2 | 2.35823838 |
| 15 | SMG1 | 2.29254045 |
| 16 | MAP3K2 | 2.27492728 |
| 17 | TAOK3 | 2.12685029 |
| 18 | MAPKAPK3 | 2.11137399 |
| 19 | EPHB1 | 2.01319486 |
| 20 | GRK6 | 1.90520667 |
| 21 | EPHA2 | 1.71279275 |
| 22 | NEK9 | 1.60433568 |
| 23 | FES | 1.51373605 |
| 24 | TRPM7 | 1.47702720 |
| 25 | PTK6 | 1.45893134 |
| 26 | MAP3K11 | 1.42202011 |
| 27 | FGR | 1.40591259 |
| 28 | EPHB2 | 1.37231332 |
| 29 | IRAK4 | 1.36879786 |
| 30 | TYK2 | 1.34339682 |
| 31 | STK10 | 1.31229089 |
| 32 | DAPK1 | 1.29223716 |
| 33 | PRKCH | 1.28263893 |
| 34 | RIPK4 | 1.25866949 |
| 35 | CDC42BPA | 1.22042498 |
| 36 | TTN | 1.21534712 |
| 37 | CAMKK1 | 1.21017946 |
| 38 | CAMKK2 | 1.12548193 |
| 39 | NEK6 | 1.12203580 |
| 40 | ZAP70 | 1.11550757 |
| 41 | MAP3K13 | 1.11138705 |
| 42 | HCK | 1.08588116 |
| 43 | CSK | 1.06846730 |
| 44 | TBK1 | 0.99026533 |
| 45 | NME1 | 0.98817571 |
| 46 | SIK2 | 0.97732360 |
| 47 | MAP2K3 | 0.96026424 |
| 48 | TGFBR2 | 0.95884990 |
| 49 | LRRK2 | 0.94708269 |
| 50 | MARK2 | 0.94096531 |
| 51 | TTK | 0.91880083 |
| 52 | FGFR1 | 0.91504984 |
| 53 | PRKCI | 0.90835236 |
| 54 | ITK | 0.88244481 |
| 55 | GRK7 | 0.85717672 |
| 56 | EEF2K | 0.84950574 |
| 57 | STK38 | 0.84406701 |
| 58 | IGF1R | 0.81292857 |
| 59 | KIT | 0.80575108 |
| 60 | BTK | 0.80019992 |
| 61 | CDK6 | 0.79188412 |
| 62 | ICK | 0.77728489 |
| 63 | RPS6KA2 | 0.76541767 |
| 64 | MAP3K5 | 0.76434125 |
| 65 | PRKCQ | 0.75821098 |
| 66 | ERBB2 | 0.75082773 |
| 67 | DAPK3 | 0.70510836 |
| 68 | LCK | 0.69375522 |
| 69 | MAP3K10 | 0.65358413 |
| 70 | MAP3K7 | 0.64768832 |
| 71 | KSR2 | 0.63639553 |
| 72 | RPS6KL1 | 0.63321102 |
| 73 | RPS6KC1 | 0.63321102 |
| 74 | YES1 | 0.62569174 |
| 75 | PTK2 | 0.62044644 |
| 76 | MAP3K6 | 0.61245255 |
| 77 | RPS6KA6 | 0.60930633 |
| 78 | MARK3 | 0.58760576 |
| 79 | FER | 0.58489817 |
| 80 | SGK3 | 0.58287372 |
| 81 | PNCK | 0.58275904 |
| 82 | NTRK1 | 0.57664281 |
| 83 | FYN | 0.57084066 |
| 84 | SYK | 0.54837550 |
| 85 | TESK1 | 0.54406013 |
| 86 | RPS6KA4 | 0.54210371 |
| 87 | EGFR | 0.53992866 |
| 88 | SGK1 | 0.53225389 |
| 89 | MAPK12 | 0.52703322 |
| 90 | CLK1 | 0.52414796 |
| 91 | STK38L | 0.52112455 |
| 92 | JAK1 | 0.50473054 |
| 93 | PRKD3 | 0.50408106 |
| 94 | GRK5 | 0.49070314 |
| 95 | SGK2 | 0.48471011 |
| 96 | BCR | 0.47712095 |
| 97 | CSF1R | 0.47648678 |
| 98 | MAP3K14 | 0.47423986 |
| 99 | PDPK1 | 0.47314687 |
| 100 | ARAF | 0.45617099 |
| 101 | LIMK1 | 0.44238809 |
| 102 | MATK | 0.44176993 |
| 103 | MAP3K8 | 0.44056037 |
| 104 | ABL1 | 0.40991595 |
| 105 | MAP3K1 | 0.40290338 |
| 106 | PIK3CG | 0.39821035 |
| 107 | TAOK1 | 0.39445312 |
| 108 | MAPKAPK2 | 0.37031074 |
| 109 | IKBKB | 0.35573612 |
| 110 | TXK | 0.35167964 |
| 111 | MAP2K4 | 0.35093282 |
| 112 | HIPK2 | 0.34284170 |
| 113 | CAMK1 | 0.33829493 |
| 114 | ROCK2 | 0.33788119 |
| 115 | PTK2B | 0.33668874 |
| 116 | CAMK4 | 0.33096355 |
| 117 | DYRK1B | 0.32733191 |
| 118 | ADRBK2 | 0.31163281 |
| 119 | JAK2 | 0.30065111 |
| 120 | LYN | 0.27556540 |
| 121 | PDK1 | 0.27034737 |
| 122 | CDK12 | 0.26270289 |
| 123 | RET | 0.25814788 |
| 124 | JAK3 | 0.25634601 |
| 125 | PRKCE | 0.25331351 |
| 126 | ERBB3 | 0.24558363 |
| 127 | TEC | 0.24510127 |
| 128 | CDK4 | 0.24451167 |
| 129 | MAPKAPK5 | 0.23098259 |
| 130 | MAP3K9 | 0.23040021 |
| 131 | PIM2 | 0.22289115 |
| 132 | EPHA3 | 0.22235945 |
| 133 | PRKCD | 0.21991438 |
| 134 | CAMK2G | 0.21796712 |
| 135 | PKN1 | 0.20976791 |
| 136 | SRC | 0.18515669 |
| 137 | IKBKE | 0.18307087 |
| 138 | PRKAA2 | 0.17893739 |
| 139 | PAK4 | 0.14579967 |
| 140 | ILK | 0.13036675 |
| 141 | SIK1 | 0.11979758 |
| 142 | PRPF4B | 0.09222480 |
| 143 | STK24 | 0.08784028 |
| 144 | MAP3K3 | 0.08494506 |
| 145 | CDK8 | 0.08160318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 8.77870725 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 6.29485368 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.47671873 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.19128713 |
| 5 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 4.02050954 |
| 6 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.57131853 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 3.56635251 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.10677049 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.00835543 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.68261574 |
| 11 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.66476014 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.39909304 |
| 13 | Prion diseases_Homo sapiens_hsa05020 | 2.12985997 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.10405584 |
| 15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.92396365 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.91906892 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.89421743 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.64541289 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.62179308 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.60410899 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53858742 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52474055 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.52455735 |
| 24 | Amoebiasis_Homo sapiens_hsa05146 | 1.46770237 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43296940 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39614701 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.36994271 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.34991972 |
| 29 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.28320735 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26966771 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.19846678 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17961799 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.16549934 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13322954 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13253518 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12711629 |
| 37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10521295 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.09753775 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08112878 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05737377 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03976261 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01596706 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99847615 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92353774 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90632542 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 0.90408164 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.87989245 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79185388 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78144339 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75705399 |
| 51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74705401 |
| 52 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74010465 |
| 53 | Tight junction_Homo sapiens_hsa04530 | 0.72978918 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70723881 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70305229 |
| 56 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70169505 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70023454 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 0.68283873 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67584354 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.67456861 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66792048 |
| 62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65320586 |
| 63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65012681 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64299115 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62089457 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61338448 |
| 67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59900556 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.59391330 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56516216 |
| 70 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54267216 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52663201 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50592858 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.49251676 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.48018199 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47316434 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47242029 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.45746443 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45243686 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43469107 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41418384 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40886015 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40631858 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.38979264 |
| 84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38050718 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37981052 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37050303 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36685719 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.36644031 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.36357857 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36009768 |
| 91 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.35608353 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34970882 |
| 93 | Adherens junction_Homo sapiens_hsa04520 | 0.34205306 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.33286873 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32671188 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31996806 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31600282 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31079539 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30503295 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30111054 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30027476 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29768396 |
| 103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29598968 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29111879 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.28739509 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27995317 |
| 107 | Renin secretion_Homo sapiens_hsa04924 | 0.27853711 |
| 108 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27168362 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26835632 |
| 110 | Morphine addiction_Homo sapiens_hsa05032 | 0.26476633 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26005939 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25025497 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25011162 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.24840584 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24555962 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.21814026 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.21813907 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21810771 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.21334535 |
| 120 | Measles_Homo sapiens_hsa05162 | 0.20543306 |
| 121 | Influenza A_Homo sapiens_hsa05164 | 0.20005806 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19470471 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18965093 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18762084 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17812575 |
| 126 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.16842067 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.15659147 |
| 128 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.15296436 |
| 129 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14676561 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14669074 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.12563164 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.12396860 |
| 133 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.12262187 |
| 134 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.10035088 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.09514019 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.09197454 |
| 137 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.07720070 |
| 138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.07461776 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.07387225 |
| 140 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.07193844 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.06888415 |

